Filing Details
- Accession Number:
- 0001069530-20-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-24 16:49:36
- Reporting Period:
- 2020-09-24
- Accepted Time:
- 2020-09-24 16:49:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069530 | Cassava Sciences Inc | SAVA | Pharmaceutical Preparations (2834) | 911911336 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1133806 | Remi Barbier | C/O Cassava Sciences, Inc. 7801 N. Capital Of Texas Hwy.; Suite 260 Austin TX 78731 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-24 | 10,000 | $9.59 | 1,078,855 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $9.48 to $9.67 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.
Billionaire Hedge Funds
